Laia Vives-Adrián

Laia Vives-Adrián

Auto-generated profile, based on publicly available information

Laia Vives-Adrián

Institut de Biologia Molecular de Barcelona (CSIC), Parc Científic de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LLLonneke van der Linden
Lonneke van der Linden
LVLaia Vives-Adrián
Laia Vives-Adrián
BSBarbara Selisko
Barbara Selisko
CFCristina Ferrer-Orta
Cristina Ferrer-Orta
XLXinran Liu
Xinran Liu
FKFrank J M van Kuppeveld
Frank J M van Kuppeveld
The genus Enterovirus of the family Picornaviridae contains many important human pathogens (e.g., poliovirus, coxsackievirus, rhinovirus, and enterovirus 71) for which no antiviral drugs are available. The viral RNA-dependent RNA polymerase is an attractive target for antiviral therapy. Nucleoside-based inhibitors have broad-spectrum activity but often exhibit off-target effects. Most non-nucleoside inhibitors (NNIs) target surface cavities, which are structurally more flexible than the nucleotide-binding pocket, and hence have a more narrow spectrum of activity and are more prone to resistance development. Here, we report a novel NNI, GPC-N114 (2,2'-[(4-chloro-1,2-phenylene)bis(oxy)]bis(5-nitro-benzonitrile)) with broad-spectrum activity against enteroviruses and cardioviruses (another genus in the picornavirus family). Surprisingly, coxsackievirus B3 (CVB3) and poliovirus displayed a high genetic barrier to resistance against GPC-N114. By contrast, EMCV, a cardiovirus, rapidly acquired resistance due to mutations in 3Dpol. In vitro polymerase activity assays showed that GPC-N114 i) inhibited the elongation activity of recombinant CVB3 and EMCV 3Dpol, (ii) had reduced activity against EMCV 3Dpol with the resistance mutations, and (iii) was most efficient in inhibiting 3Dpol when added before the RNA template-primer duplex. Elucidation of a crystal structure of the inhibitor bound to CVB3 3Dpol confirmed the RNA-binding channel as the target for GPC-N114. Docking studies of the compound into the crystal structures of the compound-resistant EMCV 3Dpol mutants suggested that the resistant phenotype is due to subtle changes that interfere with the binding of GPC-N114 but not of the RNA template-primer. In conclusion, this study presents the first NNI that targets the RNA template channel of the picornavirus polymerase and identifies a new pocket that can be used for the design of broad-spectrum inhibitors. Moreover, this study provides important new insight into the plasticity of picornavirus polymerases at the template binding site. Virus replication relies on multiplication of viral genomes by viral polymerases. For enteroviruses, a large group of clinically important human pathogens for which no antiviral therapy is available, this function is performed by 3Dpol, the RNA-dependent RNA polymerase. 3Dpol is therefore an attractive target for novel antiviral strategies. Most polymerase inhibitors identified today are nucleoside analogs, a class of compounds that exert broad-spectrum activity but often suffer from off-target effects. Non-nucleoside inhibitors on the other hand, in general have a more narrow spectrum of activity and are more prone to resistance development because in most cases they bind the surface of the enzyme which is less conserved and structurally more flexible. In this study, we present the identification of GPC-N114 as a non-nucleoside inhibitor of 3Dpol with broad-spectrum antiviral activity against both enteroviruses and cardioviruses, which also belong to the picornavirus family. Remarkably, it acts by targeting the RNA template-primer binding site in the core of 3Dpol, making GPC-N114 the first anti-picornaviral compound with this mechanism of action. Thus, the characterization of GPC-N114 has led to the identification of a novel drug-binding pocket in 3Dpol that can serve as a starting point for antiviral drug design.

25 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
APAngela Pickl-Herk
Angela Pickl-Herk
DLDaniel Luque
Daniel Luque
LVLaia Vives-Adrián
Laia Vives-Adrián
JQJordi Querol-Audí
Jordi Querol-Audí
Damià GarrigaDamià Garriga
Damià Garriga
JCJose Caston
Jose Caston
Significance: Human rhinoviruses (HRVs) cause the common cold and exacerbate chronic pulmonary diseases. Their single-stranded RNA genome is protected by an icosahedral capsid and must be released into the host cell cytosol for translation and replication. Using X-ray and cryo-EM analyses, we identified structural alterations that take place in the virus architecture during infection. In acidic endosomes in vivo and in our experimental conditions, the native virion is converted into the expanded, porous uncoating intermediate A-particle. This is accompanied by altered RNA–protein contacts at the inner capsid wall, leading to major changes in RNA conformation that result in a well-organized RNA layer. These rearrangements suggest that the RNA–protein interactions prepare RNA and facilitate its subsequent egress via a well-ordered mechanism.

15 May 2014 in Journal of Virology
Verified
Journal Article
Open access
PDF file
LVLaia Vives-Adrian
Laia Vives-Adrian
CLCelia Lujan
Celia Lujan
BOBaldo Oliva
Baldo Oliva
LLLonneke van der Linden
Lonneke van der Linden
BSBarbara Selisko
Barbara Selisko
Núria VerdaguerNúria Verdaguer
Núria Verdaguer
Encephalomyocarditis virus (EMCV) is a member of the Cardiovirus genus within the large Picornaviridae family, which includes a number of important human and animal pathogens. The RNA-dependent RNA polymerase (RdRp) 3D pol is a key enzyme for viral genome replication. In this study, we report the X-ray structures of two different crystal forms of the EMCV RdRp determined at 2.8- and 2.15-Å resolution. The in vitro elongation and VPg uridylylation activities of the purified enzyme have also been demonstrated. Although the overall structure of EMCV 3D pol is shown to be similar to that of the known RdRps of other members of the Picornaviridae family, structural comparisons show a large reorganization of the active-site cavity in one of the crystal forms. The rearrangement affects mainly motif A, where the conserved residue Asp240, involved in ribonucleoside triphosphate (rNTP) selection, and its neighbor residue, Phe239, move about 10 Å from their expected positions within the ribose binding pocket toward the entrance of the rNTP tunnel. This altered conformation of motif A is stabilized by a cation-π interaction established between the aromatic ring of Phe239 and the side chain of Lys56 within the finger domain. Other contacts, involving Phe239 and different residues of motif F, are also observed. The movement of motif A is connected with important conformational changes in the finger region flanked by residues 54 to 63, harboring Lys56, and in the polymerase N terminus. The structures determined in this work provide essential information for studies on the cardiovirus RNA replication process and may have important implications for the development of new antivirals targeting the altered conformation of motif A. IMPORTANCE The Picornaviridae family is one of the largest virus families known, including many important human and animal pathogens. The RNA-dependent RNA polymerase (RdRp) 3D pol is a key enzyme for picornavirus genome replication and a validated target for the development of antiviral therapies. Solving the X-ray structure of the first cardiovirus RdRp, EMCV 3D pol , we captured an altered conformation of a conserved motif in the polymerase active site (motif A) containing the aspartic acid residue involved in rNTP selection and binding. This altered conformation of motif A, which interferes with the correct positioning of the rNTP substrate in the active site, is stabilized by a number of residues strictly conserved among picornaviruses. The rearrangements observed suggest that this motif A segment is a dynamic element that can be modulated by external effectors, either activating or inhibiting enzyme activity, and this type of modulation appears to be general to all picornaviruses.

1 April 2015 in Journal of Virology
Verified
Journal Article
Open access
PDF file
LVLaia Vives-Adrián
Laia Vives-Adrián
Damià GarrigaDamià Garriga
Damià Garriga
MBMònica Buxaderas
Mònica Buxaderas
JFJoana Fraga
Joana Fraga
PPPereira Pedro
Pereira Pedro
Núria VerdaguerNúria Verdaguer
Núria Verdaguer
The complexity of viral RNA synthesis and the numerous participating factors require a mechanism to topologically coordinate and concentrate these multiple viral and cellular components, ensuring a concerted function. Similarly to all other positive-strand RNA viruses, picornaviruses induce rearrangements of host intracellular membranes to create structures that act as functional scaffolds for genome replication. The membrane-targeting proteins 2B and 2C, their precursor 2BC, and protein 3A appear to be primarily involved in membrane remodeling. Little is known about the structure of these proteins and the mechanisms by which they induce massive membrane remodeling. Here we report the crystal structure of the soluble region of hepatitis A virus (HAV) protein 2B, consisting of two domains: a C-terminal helical bundle preceded by an N-terminally curved five-stranded antiparallel β-sheet that displays striking structural similarity to the β-barrel domain of enteroviral 2A proteins. Moreover, the helicoidal arrangement of the protein molecules in the crystal provides a model for 2B-induced host membrane remodeling during HAV infection.IMPORTANCENo structural information is currently available for the 2B protein of any picornavirus despite it being involved in a critical process in viral factory formation: the rearrangement of host intracellular membranes. Here we present the structure of the soluble domain of the 2B protein of hepatitis A virus (HAV). Its arrangement, both in crystals and in solution under physiological conditions, can help to understand its function and sheds some light on the membrane rearrangement process, a putative target of future antiviral drugs. Moreover, this first structure of a picornaviral 2B protein also unveils a closer evolutionary relationship between the hepatovirus and enterovirus genera within thePicornaviridaefamily.

29 September 2011 in Acta Crystallographica Section F Structural Biology and Crystallization Communications
Verified
Journal Article
Closed access
Damià GarrigaDamià Garriga
Damià Garriga
LVLaia Vives-Adrián
Laia Vives-Adrián
MBMònica Buxaderas
Mònica Buxaderas
FFFrederico Ferreira-Da-Silva
Frederico Ferreira-Da-Silva
BABruno Almeida
Bruno Almeida
Núria VerdaguerNúria Verdaguer
Núria Verdaguer